Columbia University Medical Center researchers have created a way to develop personalized gene therapies for patients with retinitis pigmentosa, a leading cause of vision loss.
Scientists at the New York Stem Cell Foundation and CUMC have created the first disease-specific embryonic stem cell line using nuclear transfer technology.
Using stem cells from patients, P&S researchers have created a model of age-related macular degeneration in a dish, which may lead personalized treatments to prevent vision loss.
For the first time, scientists have successfully transformed human stem cells into functional lung and airway cells.
Columbia has honored Philipp E. Scherer, PhD for helping usher in a new understanding of fat and its role in diabetes and other metabolic diseases.
Stem cells created from the skin of patients with a rare form of diabetes have been used to elucidate an important biochemical pathway for beta-cell failure in diabetes.